Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

November 1, 1999; Volume 40,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Larson, Steven M.

    1. You have access
      Pharmacokinetics and Dosimetry of an α-Particle Emitter Labeled Antibody: 213Bi-HuM195 (Anti-CD33) in Patients with Leukemia
      George Sgouros, Åse M. Ballangrud, Joseph G. Jurcic, Michael R. McDevitt, John L. Humm, Yusuf E. Erdi, Bipin M. Mehta, Ronald D. Finn, Steven M. Larson and David A. Scheinberg
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1935-1946;
  2. Leach, Steven D.

    1. You have access
      Optimal Interpretation of FDG PET in the Diagnosis, Staging and Management of Pancreatic Carcinoma
      Dominique Delbeke, D. Michael Rose, William C. Chapman, C. Wright Pinson, J. Kelly Wright, R. Daniel Beauchamp, Yu Shyr and Steven D. Leach
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1784-1791;
  3. Lin, Qun

    1. You have access
      Dual-Label Studies with [125I]-3(R)/[131I]-3(S)-BMIPP Show Similar Metabolism in Rat Tissues
      Florian T. Mokler, Qun Lin, Huimin Luo, Daniel W. McPherson, Arnold L. Beets, Andreas Bockisch, Joachim Kropp and F.F. (Russ) Knapp
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1918-1927;
  4. Luo, Huimin

    1. You have access
      Dual-Label Studies with [125I]-3(R)/[131I]-3(S)-BMIPP Show Similar Metabolism in Rat Tissues
      Florian T. Mokler, Qun Lin, Huimin Luo, Daniel W. McPherson, Arnold L. Beets, Andreas Bockisch, Joachim Kropp and F.F. (Russ) Knapp
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1918-1927;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 11
November 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire